Deferasirox 69539-0021-30
- Manufacturer
- Msn Laboratories Private Limited
- Dosage Form
- Tablet, For Suspension
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- November 20, 2019
- Listing Expires
- December 31, 2026
- Application
- ANDA209878
Need to source Deferasirox? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Deferasirox | 125 mg/1 |
Drug Class
Iron Chelator [EPC]Cytochrome P450 1A2 Inhibitors [MoA]Cytochrome P450 2C8 Inhibitors [MoA]
Selected Package
69539-0021-30Selected30 TABLET, FOR SUSPENSION in 1 BOTTLE (69539-021-30)
Other packages for this product(3)
10 BLISTER PACK in 1 CARTON (69539-021-06) / 10 TABLET, FOR SUSPENSION in 1 BLISTER PACK (69539-021-11)
90 TABLET, FOR SUSPENSION in 1 BOTTLE (69539-021-90)
1000 TABLET, FOR SUSPENSION in 1 BOTTLE (69539-021-99)